Cancer is a group of more than 100 diseases that have two important things in common. One is that certain cells in the body become abnormal. Another is that the body keeps producing large numbers of these abnormal cells.
What is New in Leukemia?
1. Novel Diagnostic Tools Help Predict Drug Resistance in Leukemia PatientsUsing RNA epigenetics and chromatin structures as diagnostic tools can help predict and reduce drug resistance in treating patients with leukemia. Drug resistance is a major obstacle to effective treatment for patients with cancer and leukemia. Epigenetic modifying drugs have been proven effective for some patients with hematologic malignancies, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Read More..
Latest Publications and Research on LeukemiaHomogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement. - Published by PubMed
Second cancers in Hodgkin's lymphoma long-term survivals: A 60-year single institutional experience with real-life cohort of 871 patients. - Published by PubMed
Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions. - Published by PubMed
Contributions of a regional approach to document hematologic disease in Mexico: a 10-year experience in an open population. - Published by PubMed
Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement. - Published by PubMed